Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

In vitro degradation and biocompatibility evaluation of fully biobased thermoplastic elastomers consisting of poly(β-myrcene) and poly( -lactide) as stent coating

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Evaluation of Bioresorbable Polymers As Potential Stent Materialin Vivo Degradation Behavior and Histocompatibility

In Vivo Degradation of Copolymers Prepared from L-Lactide, 1,3-Trimethylene Carbonate and Glycolide As Coronary Stent Materials

Improved Mechanical Properties of Poly( L ‐lactic Acid) Stent Coated by Poly( D , L ‐lactic Acid) and Poly( L ‐lactic‐co‐glycolic Acid) Biopolymer Blend

New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets

Effect of Trimethylene Carbonate Segments on the Structure and Properties of Poly(l‐lactide‐glycolide‐trimethylene Carbonate) Terpolymers for Biodegradable Vascular Stents

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

Surface Patterning of a Novel PEG‐functionalized Poly‐l‐lactide Polymer to Improve Its Biocompatibility: Applications to Bioresorbable Vascular Stents

In Vitro Degradation of Poly[(L‐lactide)‐co‐(trimethylene Carbonate)] Copolymers and a Composite with Poly[(L‐lactide)‐co‐glycolide] Fibers As Cardiovascular Stent Material

3D printed peripheral vascular stents based on degradable poly(trimethylene carbonate-b-(L-lactide-ran-glycolide)) terpolymer

Computational and Experimental Investigation into Mechanical Performances of Poly-L-Lactide Acid (PLLA) Coronary Stents

Artificial Coronary Vascular Stents Fabrication Using Biodegradable Material Compounds of PLA/PGA-co-Chitosan

Hybrid interpenetrating network of polyester coronary stent with tunable biodegradation and mechanical properties

In Vitro Degradation Behavior of L-Lactide/Trimethylene Carbonate/Glycolide Terpolymers and A Composite with Poly(L-Lactide-Co-Glycolide) Fibers

Totally Bioresorbable Composites Prepared from Poly(l‐lactide)‐co‐(trimethylene Carbonate) Copolymers and Poly(l‐lactide)‐co‐(glycolide) Fibers As Cardiovascular Stent Material

Characterization of Tissue Responses and Degradation Behavior of Heparin-Immobilized Copolymer for Drug-Eluting Stents

<scp>3D</scp> printed peripheral vascular stents based on degradable poly(<scp>trimethylene carbonate‐b‐(L‐lactide‐ran‐glycolide)</scp>) terpolymer

Biodegradable Phosphorylcholine Copolymer for Cardiovascular Stent Coating.

A Novel Biodegradable Copolymer for Coronary Artery Stent: Preparation and its Biocompatibility in vivo

Covalently-Attached, Surface-Eroding Polymer Coatings on Magnesium Alloys for Corrosion Control and Temporally Varying Support of Cell Adhesion